Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aromatase inhibitors in ovulation induction.

Mohamed F Mitwally1, Robert F Casper

  • 1Department of Obstetrics and Gynecology, University of Toronto, and The Samuel Lununfeld Research Institute, Mount Sinai Hospital, Toronto, Canada.

Seminars in Reproductive Medicine
|April 15, 2004
PubMed
Summary

Aromatase inhibitors are effective oral medications for inducing ovulation in anovulatory patients, showing promising pregnancy rates. They may replace clomiphene citrate (CC) as a primary infertility treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-evaluating endometrial injury for IVF: was a promising approach abandoned prematurely? A critical review.

Reproductive biomedicine online·2026
Same author

Moonshots.

Reproductive biomedicine online·2025
Same author

PGT-A: Houston, we have a problem.

Journal of assisted reproduction and genetics·2023
Same author

PGT-A in patients with a single blastocyst.

Journal of assisted reproduction and genetics·2023
Same author

A decrease in endometrial thickness before embryo transfer is not associated with preterm birth and placenta-mediated pregnancy complications.

Reproductive biomedicine online·2022
Same author

Observations on clinical assessment of endometrial receptivity.

Fertility and sterility·2022

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology

Background:

  • Anovulation, particularly WHO type II, presents a significant challenge in infertility treatment.
  • Current ovulation induction methods have limitations, necessitating exploration of novel therapeutic agents.

Purpose of the Study:

  • To review the efficacy and safety of third-generation aromatase inhibitors for ovulation induction.
  • To discuss the potential of aromatase inhibitors in assisted reproductive technologies, including combination therapy with gonadotropins.

Main Methods:

  • Review of existing literature on aromatase inhibitors in ovulation induction.
  • Analysis of clinical outcomes, including pregnancy rates and gonadotropin requirements.

Main Results:

  • Aromatase inhibitors demonstrate high potency and specificity in inhibiting estrogen production.

Related Experiment Videos

  • Successful ovulation induction and promising pregnancy rates were observed in WHO type II anovulatory patients.
  • Combined use with gonadotropins significantly reduced required gonadotropin dosage for controlled ovarian hyperstimulation.

    • Conclusions:

    • Aromatase inhibitors offer an efficient, safe, and advantageous alternative to clomiphene citrate (CC) for ovulation induction.
    • These agents are poised to become the primary treatment for ovulation induction, potentially replacing CC.
    • Further research may expand the role of aromatase inhibitors in assisted reproductive technologies, alone or with recombinant FSH.